Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer

被引：0

作者：

A J Weickhardt

D S Williams

C K Lee

F Chionh

J Simes

C Murone

K Wilson

M M Parry

K Asadi

A M Scott

C J A Punt

I D Nagtegaal

T J Price

J M Mariadason

N C Tebbutt

机构：

[1] Ludwig Institute for Cancer Research,Department of Anatomical Pathology

[2] Melbourne – Austin Branch,undefined

[3] Austin Health,undefined

[4] National Health and Medical Research Council Clinical Trials Centre,undefined

[5] University of Sydney,undefined

[6] Academic Medical Center,undefined

[7] University of Amsterdam,undefined

[8] Radboud University Nijmegen Medical Center,undefined

[9] The Queen Elizabeth Hospital and University of Adelaide,undefined

[10] Ludwig Oncology Unit,undefined

[11] Austin Hospital,undefined

来源：

British Journal of Cancer | 2015年 / 113卷

关键词：

bevacizumab; VEGF; colorectal cancer; biomarkers; prediction;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：37 / 45

页数：8

共 50 条

[31] Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab [J].

A K Koutras ;

A G Antonacopoulou ;

A G Eleftheraki ;

F-I Dimitrakopoulos ;

A Koumarianou ;

I Varthalitis ;

F Fostira ;

J Sgouros ;

E Briasoulis ;

E Bournakis ;

D Bafaloukos ;

I Bompolaki ;

E Galani ;

K T Kalogeras ;

D Pectasides ;

G Fountzilas ;

H P Kalofonos .

The Pharmacogenomics Journal, 2012, 12 :468-475

[32] Vascular endothelial growth factor and psychosocial factors in colorectal cancer [J].

Sharma, A. ;

Greenman, J. ;

Sharp, D. M. ;

Walker, L. G. ;

Monson, J. R. T. .

PSYCHO-ONCOLOGY, 2008, 17 (01) :66-73

[33] Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer [J].

Nakayama, Y ;

Sako, T ;

Shibao, K ;

Okazaki, K ;

Rempo, N ;

Onitsuka, K ;

Minagawa, N ;

Akahane, K ;

Nagashima, N ;

Nagata, N ;

Itoh, H .

ANTICANCER RESEARCH, 2002, 22 (04) :2437-2442

[34] Serum vascular endothelial growth factor: A new tumor marker in colorectal cancer [J].

Chin, KF ;

Kumar, H ;

Greenman, J ;

Monson, JRT .

JOURNAL OF CLINICAL LIGAND ASSAY, 1999, 22 (04) :367-370

[35] Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab [J].

Guijarro-Munoz, Irene ;

Sanchez, Antonio ;

Martinez-Martinez, Esther ;

Garcia, Jose M. ;

Salas, Clara ;

Provencio, Mariano ;

Alvarez-Vallina, Luis ;

Sanz, Laura .

MEDICAL ONCOLOGY, 2013, 30 (02)

[36] Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab [J].

Irene Guijarro-Muñoz ;

Antonio Sánchez ;

Esther Martínez-Martínez ;

Jose M. García ;

Clara Salas ;

Mariano Provencio ;

Luis Álvarez-Vallina ;

Laura Sanz .

Medical Oncology, 2013, 30

[37] Immunohistochemical Expression of Fatty Acid Synthase and Vascular Endothelial Growth Factor in Primary Colorectal Cancer: a Clinicopathological Study [J].

Mohamed, Asmaa Hussein ;

Said, Nelly Mohamed .

JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (03) :485-492

[38] Expression of vascular endothelial growth factor, mitogenactivated protein kinase and p53 in human colorectal cancer [J].

Cassano, A ;

Bagalà, C ;

Battelli, C ;

Schinzari, G ;

Quirino, M ;

Ratto, C ;

Landriscina, M ;

Barone, C .

ANTICANCER RESEARCH, 2002, 22 (04) :2179-2184

[39] Expression of Monocarboxylate Transporter (MCT)-4 in Colorectal Cancer and its Role: MCT4 Contributes to the Growth of Colorectal Cancer with Vascular Endothelial Growth Factor [J].

Gotanda, Yukito ;

Akagi, Yoshito ;

Kawahara, Akihiko ;

Kinugasa, Tetsushi ;

Yoshida, Takefumi ;

Ryu, Yasuhiko ;

Shiratsuchi, Ichitaro ;

Kage, Masayoshi ;

Shirouzu, Kazuo .

ANTICANCER RESEARCH, 2013, 33 (07) :2941-2947

[40] Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [J].

Sluiter, N. R. ;

de Cuba, E. M. V. ;

Kwakman, R. ;

Meijerink, W. J. H. J. ;

Delis-van Diemen, P. M. ;

Coupe, V. M. H. ;

Belien, J. A. M. ;

Meijer, G. A. ;

de Hingh, I. H. J. T. ;

te Velde, E. A. .

CLINICAL & EXPERIMENTAL METASTASIS, 2016, 33 (04) :297-307

← 1 2 3 4 5 →